Hyperleptinemia, which occurs in obesity-related metabolic disturbances, favors the synthesis of the thyrotropin-releasing hormone via the promotion of the synthesis of the α-melanocyte-stimulating hormone and the activation of the STAT3 transcription factor [12]. This evidence concerns the gene STAT3 and obesity disorder.